EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 -0.0004
March 31, 2026 -0.0002
December 31, 2025 -0.0007
September 30, 2025 -0.0002
June 30, 2025 -0.0002
March 31, 2025 -0.0002
December 31, 2024 -0.0063
September 30, 2024 -0.18
March 31, 2024 -0.1755
December 31, 2023 0.9684
September 30, 2023 -15.44
June 30, 2023 -0.099
March 31, 2023 -0.099
December 31, 2022 -0.1575
September 30, 2022 -15.14
June 30, 2022 -0.1485
March 31, 2022 -0.819
December 31, 2021 -0.2565
September 30, 2021 -0.4995
June 30, 2021 -0.513
March 31, 2021 -0.846
December 31, 2020 -25.96
September 30, 2020 -0.1125
June 30, 2020 -0.306
Date Value
March 31, 2020 -0.108
December 31, 2019 -1.055
September 30, 2019 -0.3555
June 30, 2019 -0.063
March 31, 2019 -0.945
June 30, 2018 -0.0855
March 31, 2018 -0.0855
March 31, 2016 -4.50
December 31, 2015 -1.922
September 30, 2015 -499.50
June 30, 2015 -9.00
March 31, 2015 1.665
December 31, 2014 -8.235
September 30, 2014 -8.145
June 30, 2014 -1530.00
March 31, 2014 -4.95
December 31, 2013 -10.04
September 30, 2013 -27.09
June 30, 2013 -8.685
September 30, 2010 -45.00
June 30, 2010 -45.00
March 31, 2010 -45.00
September 30, 2009 -0.045

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
SCWorx Corp. -1.355
Health Catalyst, Inc. -0.5481
GoodRx Holdings, Inc. 0.0245
Claritev Corp. -3.491
iSpecimen, Inc. -0.9773

EPS Diluted (Quarterly) Related Metrics